BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25125458)

  • 1. Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.
    Glodzik L; Sollberger M; Gass A; Gokhale A; Rusinek H; Babb JS; Hirsch JG; Amann M; Monsch AU; Gonen O
    J Alzheimers Dis; 2015; 43(3):939-47. PubMed ID: 25125458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain N-acetylaspartate concentration is conserved throughout normal aging.
    Wu WE; Gass A; Glodzik L; Babb JS; Hirsch J; Sollberger M; Achtnichts L; Amann M; Monsch AU; Gonen O
    Neurobiol Aging; 2012 Oct; 33(10):2440-7. PubMed ID: 22245316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global brain volume and N-acetyl-aspartate decline over seven decades of normal aging.
    Kirov II; Sollberger M; Davitz MS; Glodzik L; Soher BJ; Babb JS; Monsch AU; Gass A; Gonen O
    Neurobiol Aging; 2021 Feb; 98():42-51. PubMed ID: 33232854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
    Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
    AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total brain N-acetylaspartate: a new measure of disease load in MS.
    Gonen O; Catalaa I; Babb JS; Ge Y; Mannon LJ; Kolson DL; Grossman RI
    Neurology; 2000 Jan; 54(1):15-9. PubMed ID: 10636119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.
    Rovaris M; Gallo A; Falini A; Benedetti B; Rossi P; Comola M; Scotti G; Comi G; Filippi M
    Arch Neurol; 2005 Jun; 62(6):898-902. PubMed ID: 15956160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The whole-brain N-acetylaspartate correlates with education in normal adults.
    Glodzik L; Wu WE; Babb JS; Achtnichts L; Amann M; Sollberger M; Monsch AU; Gass A; Gonen O
    Psychiatry Res; 2012 Oct; 204(1):49-54. PubMed ID: 23177924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
    Kantarci K; Weigand SD; Petersen RC; Boeve BF; Knopman DS; Gunter J; Reyes D; Shiung M; O'Brien PC; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
    Neurobiol Aging; 2007 Sep; 28(9):1330-9. PubMed ID: 16860440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
    Achtnichts L; Gonen O; Rigotti DJ; Babb JS; Naegelin Y; Penner IK; Bendfeldt K; Hirsch J; Amann M; Kappos L; Gass A
    Eur J Radiol; 2013 Dec; 82(12):e848-52. PubMed ID: 24041438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.